Navigation Links
K-State specialist in tick-borne pathogens receives $1.8 million grant
Date:12/7/2007

to get rid of.

"It's like the enemy entering into a battlefield and knowing exactly where the landmines are and diffusing them all," Ganta said.

Over the last five years, Ganta's research team has been working under a prior federal grant, also from the National Institutes of Health, to uncover exactly how the bacteria works. They recreated the bacteria using cells from mice and from ticks. The current study revealed that the tick cells are what made the difference, and that the tick's ecology changes the bacteria by adding proteins, enabling bacteria to slip by the immune system.

"Understanding the molecular basis for persistence by these bacteria has been critical in developing effective methods to control this and other tick-borne pathogens," Ganta said. "Our research is focused on understanding the pathogen evasion mechanisms, and then using those to defeat it."

The trick now is to learn how to turn those proteins off, leaving the bacteria vulnerable, Ganta said. That's the research his new grant will fund.

Ganta said that tick-borne pathogens like ehrlichia chaffeensis have long been recognized as a persistent concern for the health of several companion animals and livestock. The number of cases in humans has also risen in recent years, increasing the threat to public health.

The hope is that once Ganta comes up with a way to fight off the bacteria, that will pave the way for solutions to other forms of ehrlichia, some of which are devastating for cattle and other food animals.

The $1,825,000 grant is for five years of study at $365,000 a year.


'/>"/>

Contact: Roman Ganta
rganta@k-state.edu
785-532-4612
Kansas State University
Source:Eurekalert

Page: 1 2

Related biology news :

1. K-State Veterinary Lab routinely tests for bluetongue virus
2. K-State chemistry professor to receive Masao Horiba award
3. K-State sociologists use Department of Energy grant
4. K-State researchers findings on E. coli
5. Corporate Safe Specialists Announces Additions to R&D Team
6. Understanding, combating foodborne pathogens E. coli 0157 and salmonella
7. New magnetic separation technique might detect multiple pathogens at once
8. New system would use rotating magnetic field to detect pathogens
9. Rutgers Genetics receives $7.8 million for autism research
10. Herr receives Heinz Award for Technology, the Economy and Employment
11. UCI receives $5M from Edwards Lifesciences
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):H1N1 influenza adopted novel strategy to move from birds to humans 2H1N1 influenza adopted novel strategy to move from birds to humans 3H1N1 influenza adopted novel strategy to move from birds to humans 4Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 2Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 3Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 4Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 5Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 6Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 7Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 8Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 9Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 10Brooding fishes take up nutrients from their own children 2How cells tolerate DNA damage start signal for cell survival program identified 10736 1How cells tolerate DNA damage start signal for cell survival program identified 10736 2How cells tolerate DNA damage start signal for cell survival program identified 10736 3Carnegie Mellon customizing electric cars for cost effective urban commuting 10732 1Carnegie Mellon customizing electric cars for cost effective urban commuting 10732 2Carnegie Mellon customizing electric cars for cost effective urban commuting 10732 3NeoVista Inc Announces the Launch of VIDION ANV Therapy System in UK for Treating Wet Age Related Macular Degeneration 61416 1NeoVista Inc Announces the Launch of VIDION ANV Therapy System in UK for Treating Wet Age Related Macular Degeneration 61416 2NeoVista Inc Announces the Launch of VIDION ANV Therapy System in UK for Treating Wet Age Related Macular Degeneration 61416 3